BMJ-Antidepressant-Suicide Link Borne Out in Review of 702 Studies
[drugawareness] BMJ-Antidepressant-Suicide Link Borne Out in Review of 702 Studies
In the most extensive study to date, Canadian researchers found a
link between antidepressants and suicide as reported by the British
Journal. They found that SSRIs increased the chances of suicide to more
double the risk.
Looking at the past research on impairment of serotonin metabolism -
called "therapeutic" effect of antidepressants, no one should be
learn this. Impairment of serotonin metabolism has always been linked
suicide. . .and murder, and psychosis, and mania, and arson, and road
cravings for alcohol, and depression, and argumentative behavior, and
acts with no concern for punishment, etc. And they convinced the world
opposite is true in spite of all the research. How long can it take to
the world see this?
And let me repeat once again that monitoring patients taking these
DOES NOT WORK in preventing these suicides!!! The tragic suicide of
Traci Johnson while in the Eli Lilly laboratory should have been enough
for us to
realize that. The only thing I have ever seen work was invented by a
brain chemist from Israel who was working frantically to save his
after she had become intensely suicidal on Prozac and then Paxil. He
handcuffs, handcuffing her to him, and he never let her out of his
site. That is
the only effective type of monitoring I have seen in 15 years. (By the
just got notice of their first child being born - a very happy ending
horrible SSRI experience.)
Ann Blake Tracy, Ph.D.,
Executive Director, International Coalition For Drug Awareness
Author of "the Bible" on the SSRI antidepressants: "Prozac:
Panacea or Pandora? - Our Serotonin Nightmare"
& audio tape or CD set on safe withdrawal: "Help! I
Can't Get Off My Antidepressant!"
Order Number: 800-280-0730
Patients taking an SSRI were more than twice as likely to attempt
compared with patients taking placebo, especially in the early stages
the researchers found. Previously, it has been difficult to document a
between the drugs and suicidal behavior because suicides are rare and
trials involve small number of patients, they said.
``While the absolute risk of suicide is low, the widespread use of
makes this a population health concern,'' Fergusson said in his paper.
with mild illness who are being treated without supervision in the
may require closer monitoring by general practitioners, family, friends
The research may underestimate the risk of suicidal behavior, because
original trials may not have gathered reports of all suicide attempts,